Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access|
|Citation:||American Journal of Kidney Diseases, 2018; 71(5):690-700|
|Andrea K. Viecelli, Allison Tong, Emma O’Lone, Angela Ju, Camilla S. Hanson, Benedicte Sautenet, Jonathan C. Craig, Braden Manns, Martin Howell, Eric Chemla, Lai-Seong Hooi, David W. Johnson, Timmy Lee, Charmaine E. Lok, Kevan R. Polkinghorne, Robert R. Quinn, Tushar Vachharajani, Raymond Vanholder, Li Zuo, and Carmel M. Hawley, on behalf of the SONG-HD Vascular Access Workshop Investigators|
|Abstract:||Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but frequently are neither patient relevant nor measured consistently in randomized trials. A Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) consensus workshop was convened to discuss the development of a core outcome measure for vascular access. 13 patients/caregivers and 46 professionals (clinicians, policy makers, industry representatives, and researchers) attended. Participants advocated for vascular access function to be a core outcome based on the broad applicability of function regardless of access type, involvement of a multidisciplinary team in achieving a functioning access, and the impact of access function on quality of life, survival, and other access-related outcomes. A core outcome measure for vascular access required demonstrable feasibility for implementation across different clinical and trial settings. Participants advocated for a practical and flexible outcome measure with a simple actionable definition. Integrating patients’ values and preferences was warranted to enhance the relevance of the measure. Proposed outcome measures for function included “uninterrupted use of the access without the need for interventions” and “ability to receive prescribed dialysis,” but not “access blood flow,” which was deemed too expensive and unreliable. These recommendations will inform the definition and implementation of a core outcome measure for vascular access function in hemodialysis trials.|
|Keywords:||SONG-HD Vascular Access Workshop Investigators|
Vascular Access Devices
Outcome Assessment, Health Care
|Rights:||© 2018 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.|
|Appears in Collections:||Aurora harvest 8|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.